Avraham Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avraham Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10564
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avraham Pharmaceuticals Ltd (Avraham Pharmaceuticals) is a pharmaceutical company that develops novel products for treatment and prevention of neurodegenerative disorders. The company offers a product, Ladostigil. It offers product in the therapeutic area of mild cognitive impairment. Avraham Pharmaceuticals’s Ladostigil is used in neuroprotective activities for reducing oxidative stress and microglial activation and inhibiting proinflamtory cytokines and also provide a drug candidate for the potential slow progression to Alzheimer’s disease. It conducts several clinical trials in patients with MCI and Alzheimer’s disease. Avraham Pharmaceuticals is headquartered in Yavne, Israel.

Avraham Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Avraham Pharma Raises up to USD4.5 Million Financing 10
Avraham Pharma Raises USD4.5 Million in Venture Financing 12
Avraham Pharma Raises US$6 Million In Venture Financing 14
Avraham Pharmaceuticals Ltd – Key Competitors 16
Avraham Pharmaceuticals Ltd – Key Employees 17
Avraham Pharmaceuticals Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avraham Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avraham Pharma Raises up to USD4.5 Million Financing 10
Avraham Pharma Raises USD4.5 Million in Venture Financing 12
Avraham Pharma Raises US$6 Million In Venture Financing 14
Avraham Pharmaceuticals Ltd, Key Competitors 16
Avraham Pharmaceuticals Ltd, Key Employees 17

List of Figures
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avraham Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Avraham Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JSW Steel Ltd:企業のM&A・事業提携・投資動向
    JSW Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSW Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Enel Americas SA:企業の戦略・SWOT・財務情報
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Infratil Ltd (IFT):企業の財務・戦略的SWOT分析
    Infratil Ltd (IFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ReShape Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • Cebu Air Inc:戦略・SWOT・企業財務分析
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • T3D Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary T3D Therapeutics Inc (T3D Therapeutics) is a drug discovery company that develops solutions for the treatment of Alzheimer’s disease and Mild Cognitive Impairment. The company’s pipeline product include T3D-959 an optimal disease remedial therapeutic for the treatment of Alzheimer’s disease. …
  • M.C. Dean Inc:企業の戦略・SWOT・財務情報
    M.C. Dean Inc - Strategy, SWOT and Corporate Finance Report Summary M.C. Dean Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ARM Holdings plc:企業の戦略・SWOT・財務情報
    ARM Holdings plc - Strategy, SWOT and Corporate Finance Report Summary ARM Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • CBS Corporation:戦略・SWOT・企業財務分析
    CBS Corporation - Strategy, SWOT and Corporate Finance Report Summary CBS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Balt Extrusion SAS:医療機器:M&Aディール及び事業提携情報
    Summary Balt Extrusion SAS (Balt) is a medical technology company which designs, manufactures and markets interventional neuro radiology (INR) devices such as intracerebral microcatheters, extrusion tubes, vascular stents and access systems. Its product portfolio includes magic, a flow-dependant mic …
  • Primark Stores Ltd:企業の戦略・SWOT・財務分析
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Shree Renuka Sugars Ltd (RENUKA):企業の財務・戦略的SWOT分析
    Shree Renuka Sugars Ltd (RENUKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Northern Sun Mining Corp:企業の戦略・SWOT・財務分析
    Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MAXIMUS Inc (MMS):企業の財務・戦略的SWOT分析
    MAXIMUS Inc (MMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PGS ASA (PGS):企業の財務・戦略的SWOT分析
    PGS ASA (PGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • ED&F Man Holdings Ltd:企業の戦略的SWOT分析
    ED&F Man Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆